BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Erber R, Spoerl S, Mamilos A, Krupar R, Hartmann A, Ruebner M, Taxis J, Wittenberg M, Reichert TE, Spanier G, Spoerl S. Impact of Spatially Heterogeneous Trop-2 Expression on Prognosis in Oral Squamous Cell Carcinoma. Int J Mol Sci 2021;23:87. [PMID: 35008509 DOI: 10.3390/ijms23010087] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Spoerl S, Erber R, Gerken M, Taxis J, Ludwig N, Nieberle F, Biermann N, Geppert CI, Ettl T, Hartmann A, Beckhove P, Reichert TE, Spanier G, Spoerl S. A20 as a Potential New Tool in Predicting Recurrence and Patient’s Survival in Oral Squamous Cell Carcinoma. Cancers 2023;15:675. [DOI: 10.3390/cancers15030675] [Reference Citation Analysis]
2 Liu X, Deng J, Yuan Y, Chen W, Sun W, Wang Y, Huang H, Liang B, Ming T, Wen J, Huang B, Xing D. Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer. Pharmacology & Therapeutics 2022;239:108296. [DOI: 10.1016/j.pharmthera.2022.108296] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Chen K, Kostos L, Azad AA. Future directions in systemic treatment of metastatic hormone-sensitive prostate cancer. World J Urol 2022. [PMID: 36029329 DOI: 10.1007/s00345-022-04135-8] [Reference Citation Analysis]